Metabolically engineered plant cell cultures as biofactories for the production of high-value carotenoids astaxanthin and canthaxanthin
- PMID: 40769992
- PMCID: PMC12328620
- DOI: 10.1038/s41598-025-11916-9
Metabolically engineered plant cell cultures as biofactories for the production of high-value carotenoids astaxanthin and canthaxanthin
Abstract
Astaxanthin and canthaxanthin are high-value carotenoids with growing demand due to their antioxidant properties and applications in food, cosmetic, and pharmaceutical sectors. However, natural sources are limited and current production methods are often costly or unsustainable. In this study, we developed a plant-based platform for ketocarotenoid biosynthesis using metabolically engineered Nicotiana tabacum BY-2 cell suspension cultures. Specifically, we expressed a marine bacterial crtW gene (β-carotene ketolase) alone or in combination with overexpressed plant psy (phytoene synthase) and crtI (phytoene desaturase) genes. The resulting cell lines displayed visually distinct pigmentation and accumulated different ketocarotenoid profiles based on their genetic modifications. Single-gene transformants expressing crtW produced up to 50 µg g⁻¹ DW of canthaxanthin and 127 µg g⁻¹ DW of astaxanthin. Co-expression of all three genes significantly increased canthaxanthin accumulation to 788 µg g⁻¹ DW. Our results establish suspended undifferentiated plant cells as a scalable and sustainable system for ketocarotenoid production, offering a biological alternative to natural producers and chemical synthesis.
Keywords: Nicotiana tabacum BY-2 non-photosynthetic cells; Metabolic engineering; Molecular farming; Secondary metabolites; Sustainable bioproduction; Synthetic biology.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Competing interests: The authors declare no competing interests.
Figures





Similar articles
-
Oilseed-based metabolic engineering of astaxanthin and related ketocarotenoids using a plant-derived pathway: Lab-to-field-to-application.Plant Biotechnol J. 2025 Aug;23(8):3451-3464. doi: 10.1111/pbi.70148. Epub 2025 Jun 3. Plant Biotechnol J. 2025. PMID: 40457958 Free PMC article.
-
Unlocking the Potential of Medicago truncatula A17 Cell Suspension Cultures for Bioproduction of Astaxanthin and Canthaxanthin.Biotechnol Bioeng. 2025 Aug;122(8):2228-2240. doi: 10.1002/bit.29009. Epub 2025 May 2. Biotechnol Bioeng. 2025. PMID: 40317979
-
Reconstruction of the astaxanthin biosynthesis pathway in rice endosperm reveals a metabolic bottleneck at the level of endogenous β-carotene hydroxylase activity.Transgenic Res. 2017 Feb;26(1):13-23. doi: 10.1007/s11248-016-9977-x. Epub 2016 Aug 27. Transgenic Res. 2017. PMID: 27567632
-
Advances in the biosynthesis of β-carotene and its derivatives in yeast.Bioresour Technol. 2025 Nov;435:132936. doi: 10.1016/j.biortech.2025.132936. Epub 2025 Jul 3. Bioresour Technol. 2025. PMID: 40614874 Review.
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4. Cochrane Database Syst Rev. 2021. Update in: Cochrane Database Syst Rev. 2022 May 23;5:CD011535. doi: 10.1002/14651858.CD011535.pub5. PMID: 33871055 Free PMC article. Updated.
References
-
- Farré, G. et al. Travel advice on the road to carotenoids in plants. Plant. Sci.179, 28–48 (2010).
-
- Pagare, S., Bhatia, M., Tripathi, N., Pagare, S. & Bansal, Y. K. Secondary metabolites of plants and their role: overview. Curr. Trends Biotechnol. Pharm.9, 293–304 (2015).
-
- Dutta, S., Kumar, S. P. J. & Banerjee, R. A comprehensive review on astaxanthin sources, structure, biochemistry and applications in the cosmetic industry. Algal Res.74, 103168 (2023).
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources